BTCY · Biotricity Inc.
$0.12
0.00 (-1.69%)
At close · Aug 14
Going-concern doubt
— flagged Jul 14, 2026
Substantial doubt about the company's ability to continue as a going concern.
“Management has previously noted the existence of substantial doubt about our ability to continue as a going concern. Additionally, our independent registered public accounting firm included an explanatory paragraph in the report on our financial statements as of and for the years ended March 31, 2026 and 2025, respectively, noting the existence of substantial doubt about our ability to continue as a going concern.”View the 10-K filed Jul 14, 2026
Market Cap
$2.33M
Shares
20.07M
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
No Compensation Data
No Summary Compensation Table has been imported from this company's proxy statements yet.
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| Ronald McClurg | Director | Appointed | 2023-04-03 |
| David A. Rosa | Director | Appointed | 2023-04-03 |
| Chester White | Director | Appointed | 2023-04-03 |
| Waqaas Al-Siddiq | Director | Appointed | 2023-04-03 |
| Chester White | Board of Directors | Appointed | 2022-08-11 |
| Norman Betts | member of the Board of Directors of Biotricity Inc. (the "Company") and a member of the Company's Audit Committee | Resigned | 2022-08-11 |
| Patricia Kennedy | member of the Board of Directors of Biotricity Inc. (the "Company"), a member of the Company's Audit Committee, and a member of | Resigned | 2022-08-11 |
| Ronald McClurg | Board of Directors | Appointed | 2022-05-06 |
| Stephen Salmon | member of the Board of Directors | Resigned | 2022-05-06 |